As more people turn to chatbots for medical guidance, the technology is revealing both its promise and its risks

65% of U.S. doctors reportedly use OpenEvidence, which is supported in part by pharmaceutical ads.

As more people turn to chatbots for medical guidance, the technology is revealing both its promise and its risks